UnitedHealth Group’s Optum Rx will remove reauthorization requirements for more than 60 chronic disease medications on July 1.
The cuts are in addition to about 80 reauthorizations Optum Rx eliminated in March, which the company said will increase medication accessibility and improve health outcomes.
The 60-some medications include treatments for behavioral health, dry eye disease, high cholesterol, HIV and hypertension, according to a June 30 news release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit